Beverly R. Wuertz

1.2k total citations
43 papers, 935 citations indexed

About

Beverly R. Wuertz is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Beverly R. Wuertz has authored 43 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 20 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Beverly R. Wuertz's work include Peroxisome Proliferator-Activated Receptors (10 papers), Cancer-related Molecular Pathways (7 papers) and NF-κB Signaling Pathways (7 papers). Beverly R. Wuertz is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (10 papers), Cancer-related Molecular Pathways (7 papers) and NF-κB Signaling Pathways (7 papers). Beverly R. Wuertz collaborates with scholars based in United States, Malaysia and Canada. Beverly R. Wuertz's co-authors include Joseph E. De Larco, Leo T. Furcht, Frank G. Ondrey, J. Carlos Manivel, Steven A. Erickson, Douglas Yee, Mary C. Rose, Timothy J. Griffin, Diego Preciado and Wendy A. Miller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Beverly R. Wuertz

41 papers receiving 918 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beverly R. Wuertz United States 14 495 329 215 214 151 43 935
Bin Qiao China 18 353 0.7× 408 1.2× 188 0.9× 125 0.6× 90 0.6× 36 874
Ningning Zhou China 16 583 1.2× 348 1.1× 207 1.0× 139 0.6× 317 2.1× 60 1.1k
Scott Caroen United States 16 309 0.6× 340 1.0× 90 0.4× 160 0.7× 185 1.2× 68 852
Fuxiang Zhou China 20 454 0.9× 540 1.6× 275 1.3× 136 0.6× 243 1.6× 85 1.2k
Luis A. Martinez United States 11 423 0.9× 366 1.1× 172 0.8× 212 1.0× 205 1.4× 17 868
Sofia Spyridonidou Greece 15 232 0.5× 298 0.9× 211 1.0× 80 0.4× 71 0.5× 31 663
Huei‐Han Liou Taiwan 18 186 0.4× 525 1.6× 292 1.4× 72 0.3× 99 0.7× 37 809
Zhikun Ma China 19 306 0.6× 748 2.3× 302 1.4× 78 0.4× 128 0.8× 38 1.1k
Jianmin Hu China 17 270 0.5× 325 1.0× 175 0.8× 143 0.7× 220 1.5× 28 1.0k

Countries citing papers authored by Beverly R. Wuertz

Since Specialization
Citations

This map shows the geographic impact of Beverly R. Wuertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly R. Wuertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly R. Wuertz more than expected).

Fields of papers citing papers by Beverly R. Wuertz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly R. Wuertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly R. Wuertz. The network helps show where Beverly R. Wuertz may publish in the future.

Co-authorship network of co-authors of Beverly R. Wuertz

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly R. Wuertz. A scholar is included among the top collaborators of Beverly R. Wuertz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly R. Wuertz. Beverly R. Wuertz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wuertz, Beverly R., et al.. (2024). Abstract LB139: Disparities in oral precancerous lesion surveillance in the United States upper Midwest. Cancer Research. 84(7_Supplement). LB139–LB139.
2.
Samuels, Tina L., Beverly R. Wuertz, Davis Seelig, et al.. (2024). Inhaled fosamprenavir for laryngopharyngeal reflux: Toxicology and fluid dynamics modeling. Laryngoscope Investigative Otolaryngology. 9(1). e1219–e1219. 10 indexed citations
3.
Wuertz, Beverly R., et al.. (2023). Metabolic and Metabolomic Effects of Metformin in Murine Model of Pulmonary Adenoma Formation. Nutrition and Cancer. 75(3). 1014–1027. 2 indexed citations
4.
Patel, Ketan, et al.. (2023). Potential Roles of Activin in Head and Neck Squamous Cell Carcinoma Progression and Mortality. Anticancer Research. 43(12). 5299–5310.
5.
Johnston, Nikki, Tina L. Samuels, Christopher G. Goetz, et al.. (2022). Oral and Inhaled Fosamprenavir Reverses Pepsin‐Induced Damage in a Laryngopharyngeal Reflux Mouse Model. The Laryngoscope. 133(S1). S1–S11. 16 indexed citations
6.
Wuertz, Beverly R., et al.. (2021). Abstract 2568: Use of kinase inhibitors in Fanconi anemia oral cancercell lines. Cancer Research. 81(13_Supplement). 2568–2568. 1 indexed citations
7.
Hall, Jeffrey A., et al.. (2020). Effects of PPAR‐γ agonists on oral cancer cell lines: Potential horizons for chemopreventives and adjunctive therapies. Head & Neck. 42(9). 2542–2554. 9 indexed citations
8.
Miller, Kimberly A., et al.. (2020). Establishment and characterization of an inverted papilloma–associated sinonasal squamous cell carcinoma cell line. International Forum of Allergy & Rhinology. 11(5). 938–940. 2 indexed citations
9.
Wuertz, Beverly R., et al.. (2019). Chemoprevention of Lung Carcinogenesis by Dietary Nicotinamide and Inhaled Budesonide. Cancer Prevention Research. 12(2). 69–78. 9 indexed citations
10.
Gutkind, J. Silvio, Frank G. Ondrey, Denise M. Laronde, et al.. (2018). Abstract 4985: M4OC-Prevent: Clinical evaluation of metformin for oral cancer precision prevention. Cancer Research. 78(13_Supplement). 4985–4985. 2 indexed citations
11.
Antonides, Jennifer D., Beverly R. Wuertz, Wendy A. Miller, et al.. (2017). Fixed-Dose Combinations of Pioglitazone and Metformin for Lung Cancer Prevention. Cancer Prevention Research. 10(2). 116–123. 21 indexed citations
12.
Wuertz, Beverly R., et al.. (2017). Abstract 5267: Chemoprevention of lung carcinogenesis by dietary nicotinamide and inhaled budesonide. Cancer Research. 77(13_Supplement). 5267–5267. 1 indexed citations
13.
Wuertz, Beverly R., et al.. (2017). Thiazolidinediones abrogate cervical cancer growth. Experimental Cell Research. 353(2). 63–71. 12 indexed citations
14.
Antonides, Jennifer D., Beverly R. Wuertz, Wendy A. Miller, et al.. (2016). Safety and Preclinical Efficacy of Aerosol Pioglitazone on Lung Adenoma Prevention in A/J Mice. Cancer Prevention Research. 10(2). 124–132. 17 indexed citations
15.
Wuertz, Beverly R., et al.. (2015). Abstract 914: Pioglitazone and metformin as potential chemopreventative treatments in Fanconi anemia related oral squamous carcinoma. Cancer Research. 75(15_Supplement). 914–914. 2 indexed citations
16.
Rhodus, Nelson L., Frank G. Ondrey, Beverly R. Wuertz, et al.. (2014). Quantitative Proteomic Analysis of Oral Brush Biopsies Identifies Secretory Leukocyte Protease Inhibitor as a Promising, Mechanism-Based Oral Cancer Biomarker. PLoS ONE. 9(4). e95389–e95389. 24 indexed citations
17.
Caicedo‐Granados, Emiro, Lee W. Wattenberg, Beverly R. Wuertz, et al.. (2013). N‐methylnitrosourea–induced carcinoma as a model for laryngeal carcinogenesis. Head & Neck. 36(12). 1802–1806. 4 indexed citations
18.
Caicedo‐Granados, Emiro, Beverly R. Wuertz, & Frank G. Ondrey. (2011). Enforced expression of nuclear factor kappa B in p53 deficient keratinocytes induces cell cycle, angiogenic potential and tumorigenesis. Oral Oncology. 48(4). 303–310. 3 indexed citations
19.
Wuertz, Beverly R., et al.. (2008). TNF‐α Drives Matrix Metalloproteinase‐9 in Squamous Oral Carcinogenesis. The Laryngoscope. 118(8). 1395–1399. 22 indexed citations
20.
Larco, Joseph E. De, et al.. (2001). A Potential Role for Interleukin-8 in the Metastatic Phenotype of Breast Carcinoma Cells. American Journal Of Pathology. 158(2). 639–646. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bin Qiao Breakdown of academic impact, for papers by Ningning Zhou Breakdown of academic impact, for papers by Scott Caroen Breakdown of academic impact, for papers by Fuxiang Zhou Breakdown of academic impact, for papers by Luis A. Martinez Breakdown of academic impact, for papers by Sofia Spyridonidou Breakdown of academic impact, for papers by Huei‐Han Liou Breakdown of academic impact, for papers by Zhikun Ma Breakdown of academic impact, for papers by Jianmin Hu
Rankless by CCL
2026